An essential role for N-cadherin and β-catenin for progression in tongue squamous cell carcinoma and their effect on invasion and metastasis of Tca8113 tongue cancer cells

Oncology Reports

Volumn 21, Issue 5, 2009, Pages 1223-1233

  Li, Sha ^a   Jiao, Jing ^a   Lu, Zhaoming ^a   Zhang, Mingzhi ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

catenin; Invasion; Metastasis; N cadherin; Tongue squamous cell carcinoma

Indexed keywords

BETA CATENIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; GELATINASE A; GELATINASE B; NERVE CELL ADHESION MOLECULE;

ADULT; APOPTOSIS; ARTICLE; CANCER INVASION; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; METASTASIS INHIBITION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA; TUMOR GROWTH; UPREGULATION;

APOPTOSIS; BETA CATENIN; BLOTTING, WESTERN; CADHERINS; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL GROWTH PROCESSES; CELL LINE, TUMOR; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TONGUE NEOPLASMS; TRANSFECTION;

EID: 67649372884     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000345     Document Type: Article

References (47)

1. Canto MT and Devesa SS: Oral cavity and pharynx cancer inciden rates in the United States, 1975-1998. Oral Oncol 38: 610-617, 2002.
2. Hyde NC, Prvulovich E and Newman L: A new approach to pre-treatment assessment of the N0 neck in orals quamous cell carcinoma: the role of sentinel node biopsy and positron emission tomography. Oral Oncol 39: 350-360, 2003.
3. Hirohashi S and Kanai Y: Cell adhesion systemand human cancer morphogenesis. Cancer Sci 94: 575-581, 2003.
4. Hajra KM and Fearon ER: Cadherin and catenin alterations in human cancer. Genes Chromosomes Cancer 34: 255-268, 2002.
5. Yagi T and Takeichi M: Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. Genes Dev 14: 1169-1180, 2000.
6. Gumbiner BM: Regulation of cadherin-mediated adhesion in morphogenesis. Nat Rev Mol Cell Biol 6: 622-634, 2005.
7. Goodsell DS: The molecular perspective: cadherin. Stem Cell 20: 583-584, 2002.
8. Cavallaro U and Chirstofori G: Cell adhesion in tumor invasion and metastasis: loss of the glue is not enough. Biochem Biophys Acta 1552: 39-45, 2001.
9. Dejana E: Endothelial cell-cell junctions: happy together. Nat Rev Mol Cell Biol 5: 261-270, 2004.
10. Wheelock MJ and Johnson KR: Cadherins as modulators of cellular phenotype. Annu Rev Cell Dev Biol 19: 207-235, 2003.
11. Williams CL, Hayes VY, Hummel AM, Tarara JE and Halsey TJ: Regulation of E-cadherin-mediated adhesion by muscarinic acetylcholine receptors in small cell lung carcinoma. J Cell Biol 121: 643-654, 1993.
12. Garnallo C, Palacios J, Suarez A, Pizarro A, Navarro P, Quintanilla M and Cano A: Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol 142: 987-993, 1993.
13. Schipper JH, Frixen UH, Behrens J, Unger A, Jahnke K and Birchmeier W: E-cadherin expression in squamous cell carcinoma of head and neck: inverse correlation with differentiation and lymph node metastasis. Cancer Res 51: 6328-6337, 1991.
14. Pelin K, Hirvonen A and Linnainmaa K: Expression of cell adhesion molecules and connexins in gap junctional intercellular communication deficient human mesothelioma turnout cell lines and communication competent primary mesothelial cells. Carcinogenesis 15: 2673-2675, 1994.
15. Hazan RB, Kang L, Whooley BP and Borgen PI: N-cadherin promotes adhesion between invasive breast cancer cells and the stroma. Cell Adhes Commun 4: 399-411, 1997.
16. Tran NL, Nagle RB, Cress AE and Heimark RL: N-Cadherin expression in human prostate carcinoma cell lines. Anepithelial-mesenchymal transformation mediating adhesion with stromal cells. Am J Pathol 155: 787-798, 1999.
17. Li G, Satyamoorthy K and Herlyn M: N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. Cancer Res 61: 3819-3825, 2001.
18. Tomita K, van Bokhoven A, van Leenders GJ, Ruijter ET, Jansen CF, Bussemakers MJ and Schalken JA: Cadherin switching in human prostate cancer progression. Cancer Res 60: 3650-3654, 2000.
19. Islam S, Carey TE, Wolf GT, Wheelock MJ and Johnson KR: Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell-cell adhesion. J Cell Biol 135: 1643-1654, 1996.
20. Hazan RB, Phillips GR, Qiao RF, Norton L and Aaronson SA: Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol 148: 779-790, 2000.
21. Nieman MT, Prudoff RS, Johnson KR and Wheelock MJ: N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol 147: 631-644, 1999.
22. Akiyama T: Wnt/h-catenin signaling. Cytokine Growth Factor Rev 11: 273-282, 2000.
23. Morin PJ: h-Catenin signaling and cancer. Bioessays 21: 1021-1030, 1999.
24. Kawanishi J, Kato J, Sasaki K, Fujii S, Watanabe N and Niitsu Y: Loss of E-cadherin-dependent cell-cell adhesion due to mutation of the beta-catenin gene in a human cancer cell line, HSC-39. Mol Cell Biol 15: 1175-1181, 1995.
25. Polakis P: Wnt signaling and cancer. Genes Dev 14: 1837-1851, 2000.
26. Takayama T, Shiozaki H, Doki Y, et al: Aberrant expression and phosphorylation of beta-catenin in human colorectal cancer. Br J Cancer 77: 605-613, 1998.
27. Valizadeh A, Karayiannakis AJ, el-Hariry I, Kmiot W and Pignatelli M: Expression of E-cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120) in colorectal polyps. Am J Pathol 150: 1977-1984, 1997.
28. Lo Muzio L, Staibano S, Pannone G, et al: Beta- and gamma-catenin expression in oral squamous cell carcinomas. Anticancer Res 19: 3817-3826, 1999.
29. Wang L, Zhang Z, Wang Y, Zhang R and Chopp M: Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke 35: 1732-1737, 2004.
30. ΔΔCT method. Methods 25: 402-408, 2001.
31. Lu ZM, Liu HT, Xue LX, Xu PR, Gong TX and Hou GQ: An activated Notch1 signaling pathway inhibits cell proliferation and induces apoptosis in human esophageal squamous cell carcinoma cell line EC9706. Int J Oncol 32: 643-651, 2008.
32. Ziober BL Jr, Silverman SS and Kramer RH: Adhesive mechanisms regulating invasion and metastasis in oral cancer. Crit Rev Oral Biol Med 12: 499-510, 2001.
33. Hsu M, Andl T, Li G, Meinkoth JL and Herlyn M: Cadherin repertoire determines partner-specific gap junctional communication during melanoma progression. J Cell Sci 113: 1535-1542, 2000.
34. Rieger-Christ KM, Cain JW, Braasch JW, et al: Expression of classic cadherins type I in urothelial neoplastic progression. Hum Pathol 32: 18-23, 2001.
35. Nakajima S, Doi R, Toyoda E, et al: N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma. Clin Cancer Res 10: 4125-4133, 2004.
36. Rosivatz E, Becker I, Bamba M, et al: Neoexpression of N-cadherin in E-cadherin positive colon cancers. Int J Cancer 111: 711-719, 2004.
37. Hazan RB, Qiao R, Keren R, Badano I and Suyama K: Cadherin switch in tumor progression. Ann NY Acad Sci 1014: 155-163, 2004.
38. Derycke LD and Bracke ME: N-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signaling. Int J Dev Biol 48: 463-476, 2004.
39. Hsu HC, Jeng YM, Mao TL, Chu JS, Lai PL and Peng SY: ß-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis. Am J Pathol 157: 763-770, 2000.
40. Mao TL, Chu JS, Jeng YM, Lai PL and Hsu HC: Expression of mutant nuclear ß-catenin correlates with non-invasive hepatocellular carcinoma, absence of portal vein spread, and good prognosis. J Pathol 193: 95-101, 2001.
41. Wong CM, Fan ST and Ng IO: ß-catenin mutation and over-expression in hepatocellular carcinoma. Cancer 92: 136-145, 2001.
42. Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM and Shafie S: Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284: 67-68, 1980.
43. Watanabe H, Nakanishi I, Yamashita K, Hayakawa T and Okada Y: Matrix metalloproteinase-9 (92 kDa gelatinase/type IV collagenase) from U937 monoblastoid cells: correlation with cellular invasion. J Cell Sci 104: 991-999, 1993.
44. Azzam HS, Arand G, Lippman ME and Thompson EW: Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production. J Natl Cancer Inst 85: 1758-1764, 1993.
45. Deryugina EI and Quigley JP: Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 25: 9-34, 2006.
46. Hiratsuka S, Nakamura K, Iwai S, et al: MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell 2: 289-300, 2002.
47. Gartel AL, Serfas MS and Tyner AL: p21-negative regulator of the cell cycle. Proc Soc Exp Biol Med 213: 138-149, 1996.